Takeda officer reports 124,132 ADS holdings

Takeda Pharmaceutical Co. Ltd. executive Gabriele Ricci, Chief Data & Tech.

Accepted by SEC EDGAR 03/18/2026 - 06:16 AM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Takeda Pharmaceutical Co. Ltd. executive Gabriele Ricci, Chief Data & Tech. Officer, reports beneficial ownership of 124,132 American Depositary Shares. This includes 45,774 restricted stock units, each representing a contingent right to one ADS, vesting on July 1, 2026 (21,952), July 1, 2027 (16,012) and July 1, 2028 (7,810).

Insider Trade Summary

Holdings reported, no transactions

Holdings

Insider Ricci Gabriele

Role Chief Data & Tech. Officer

Type	Security	Shares	Price	Value
Holding	American Depositary Shares	--	--	--

Holdings: American Depositary Shares — 124,132 shares (Direct)

Footnotes (1)

1. F1. Includes 45,774 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one American Depositary Share. The RSUs vest on the following schedule: July 1, 2026 (21,952 shares), July 1, 2027 (16,012 shares) and July 1, 2028 (7,810 shares).

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many Takeda (TAK) American Depositary Shares does Gabriele Ricci report owning?

Gabriele Ricci reports beneficial ownership of 124,132 American Depositary Shares of Takeda. This total includes both regular shares and 45,774 restricted stock units that can convert into ADS as they vest over time.

What restricted stock units are included in Gabriele Ricci’s Takeda (TAK) holdings?

Ricci’s reported holdings include 45,774 restricted stock units (RSUs). Each RSU represents a contingent right to receive one American Depositary Share, adding to his potential future Takeda equity as the units vest on scheduled dates.

When do Gabriele Ricci’s Takeda (TAK) RSUs vest and in what amounts?

The RSUs vest in three tranches: 21,952 units on July 1, 2026, 16,012 units on July 1, 2027, and 7,810 units on July 1, 2028. Each vested RSU can convert into one American Depositary Share.

How are Gabriele Ricci’s Takeda (TAK) shares held according to this report?

The report shows direct ownership of the 124,132 American Depositary Shares, as indicated by the direct ownership code. This means the position is held in Ricci’s name rather than through an intermediary entity such as a trust or partnership.

What is Gabriele Ricci’s role at Takeda (TAK) linked to these reported holdings?

Gabriele Ricci serves as Chief Data & Tech. Officer at Takeda Pharmaceutical Co. Ltd. The reported 124,132 American Depositary Shares, including RSUs, reflect his beneficial ownership position associated with this executive role.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Ricci Gabriele

(Last) (First) (Middle)

650 E. KENDALL STREET

(Street)

CAMBRIDGE MASSACHUSETTS 02142

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
TAKEDA PHARMACEUTICAL CO LTD [ TAK ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Data & Tech. Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
American Depositary Shares	124,132(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes 45,774 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one American Depositary Share. The RSUs vest on the following schedule: July 1, 2026 (21,952 shares), July 1, 2027 (16,012 shares) and July 1, 2028 (7,810 shares).

Remarks:

Exhibit 24 Power of Attorney

	/s/ Max Heuer, by power of attorney, for Gabriele Ricci	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)